Outlook Therapeutics Faces Pivotal FDA Decision on Eye Drug Application

SELECT RESOLUTION:

1080p Format 720p Format Web Proxy

Associated Document: Outlook Therapeutics

License: Educational Use Only. Assets provided by Colegio Técnico Benjamín Herrera library index.

← Return to Material